Predictors of renal dysfunction during everolimus treatment in patients with metastatic renal cell carcinoma

被引：0
|
作者：
Mizuno, Ryuichi
Takahashi, Ryohei
Shinojima, Toshiaki
Kosaka, Takeo
Miyajima, Akira
Oya, Mototsugu
机构：
[1] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan
[2] Keio Univ, Shinjuku Ku, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15584
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sequential treatment of metastatic Renal cell carcinoma Everolimus in Therapy of metastatic Renal cell carcinoma
    Gschwend, Juergen E.
    AKTUELLE UROLOGIE, 2011, 42 (03) : A4 - A5
  • [2] Patterns of Interstitial Lung Disease During Everolimus Treatment in Patients with Metastatic Renal Cell Carcinoma
    Mizuno, Ryuichi
    Asano, Koichiro
    Mikami, Shuji
    Nagata, Hirohiko
    Kaneko, Gou
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (05) : 442 - 446
  • [3] Clinical analysis of everolimus in the treatment of metastatic renal cell carcinoma
    Ren, Zongtao
    Niu, Yunfeng
    Fan, Bo
    Wei, Shufei
    Ma, Yongliang
    Zhang, Xiaoyu
    Guo, Xiaoqiang
    Zhang, Aili
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 584 - 589
  • [4] Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
    Rossetti, Sabrina
    D'Aniello, Carmine
    Iovane, Gelsomina
    Scagliarini, Sarah
    Laterza, Maria M.
    De Vita, Fernando
    Savastano, Clementina
    Carteni, Giacomo
    Porricelli, Maria A.
    Berretta, Massimiliano
    Pisconti, Salvatore
    Facchini, Gaetano
    Cavaliere, Carla
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [5] Erectile dysfunction in patients with metastatic renal cell carcinoma
    Tsimafeyeu, I.
    Zukov, R.
    Demidov, L.
    Borisov, P.
    Kuznetsov, V.
    Leonenko, V.
    Bondarenko, A.
    Zakurdaeva, K.
    Tishova, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [6] Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma
    Bendtsen, Mathias Alro Fichtner
    Grimm, Daniela
    Bauer, Johann
    Wehland, Markus
    Wise, Petra
    Magnusson, Nils E.
    Infanger, Manfred
    Krueger, Marcus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [7] Autoimmunity and Thyroid Dysfunction During Sunitinib Treatment in Metastatic Renal Cell Carcinoma
    Karagoz, Bulent
    Bilgi, Oguz
    Ozgun, Alpaslan
    Alacacioglu, Ahmet
    Yilmaz, Bahattin
    Kandemir, Emin Goekhan
    ENDOCRINOLOGIST, 2009, 19 (05): : 224 - 225
  • [8] Pharmacogenetic Predictors for Treatment Outcome of Sunitinib in Metastatic Renal Cell Carcinoma Patients
    Park, H. S.
    Kim, H.
    Park, H.
    Kwon, W.
    Lee, J.
    Lee, M.
    Kim, H.
    Shin, S.
    Ahn, J.
    Rha, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S233 - S233
  • [9] Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
    Ki Hyang Kim
    Sang Hyun Yoon
    Hae-Jung Lee
    Hyo Song Kim
    Sang Joon Shin
    Joong Bae Ahn
    Sun Young Rha
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 853 - 860
  • [10] Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
    Kim, Ki Hyang
    Yoon, Sang Hyun
    Lee, Hae-Jung
    Kim, Hyo Song
    Shin, Sang Joon
    Ahn, Joong Bae
    Rha, Sun Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 853 - 860
12345